FullText URL | fulltext.pdf |
---|---|
Author | Ando, Eri| Nakasuka, Takamasa| Kubo, Toshio| Taniguchi, Akihiko| Ninomiya, Kiichiro| Kato, Yuka| Ichihara, Eiki| Ohashi, Kadoaki| Rai, Kammei| Hotta, Katsuyuki| Yamane, Masaomi| Miyahara, Nobuaki| Tabata, Masahiro| Maeda, Yoshinobu| Kiura, Katsuyuki| |
Keywords | pulmonary aspergilloma allergic bronchopulmonary aspergillosis disaster |
Published Date | 2022-02-01 |
Publication Title | Internal Medicine |
Volume | volume61 |
Issue | issue3 |
Publisher | JAPAN SOC INTERNAL MEDICINE |
Start Page | 379 |
End Page | 383 |
ISSN | 0918-2918 |
NCID | AA10827774 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © 2022 The Japanese Society of Internal Medicine |
File Version | publisher |
PubMed ID | 34373373 |
DOI | 10.2169/internalmedicine.7124-21 |
Web of Science KeyUT | 000752787300015 |
Related Url | isVersionOf https://doi.org/10.2169/internalmedicine.7124-21 |
FullText URL | fulltext.pdf |
---|---|
Author | Makimoto, Go| Shimonishi, Atsushi| Ohashi, Kadoaki| Ninomiya, Kiichiro| Higo, Hisao| Kato, Yuka| Fujii, Masanori| Kubo, Toshio| Ichihara, Eiki| Hotta, Katsuyuki| Tabata, Masahiro| Maeda, Yoshinobu| Kiura, Katsuyuki| |
Keywords | MET Tepotinib Non-small-cell lung cancer |
Published Date | 2022 |
Publication Title | Case Reports In Oncology |
Volume | volume15 |
Issue | issue2 |
Publisher | Karger |
Start Page | 494 |
End Page | 498 |
ISSN | 1662-6575 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © 2022 The Author(s). |
File Version | publisher |
PubMed ID | 35702678 |
DOI | 10.1159/000524326 |
Web of Science KeyUT | 000864085100005 |
Related Url | isVersionOf https://doi.org/10.1159/000524326 |
FullText URL | fulltext.pdf |
---|---|
Author | Taoka, Masataka| Makimoto, Go| Umakoshi, Noriyuki| Ninomiya, Kiichiro| Higo, Hisao| Kato, Yuka| Fujii, Masanori| Kubo, Toshio| Ichihara, Eiki| Ohashi, Kadoaki| Hotta, Katsuyuki| Tabata, Masahiro| Maeda, Yoshinobu| Kiura, Katsuyuki| |
Keywords | Hemoptysis Bronchial artery embolization Endoscopic bronchial occlusion Endobronchial Watanabe Spigot |
Published Date | 2022 |
Publication Title | Respiratory Medicine Case Reports |
Volume | volume38 |
Publisher | Elsevier |
Start Page | 101669 |
ISSN | 2213-0071 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © 2022 The Authors. |
File Version | publisher |
PubMed ID | 35646587 |
DOI | 10.1016/j.rmcr.2022.101669 |
Web of Science KeyUT | 001089212200003 |
Related Url | isVersionOf https://doi.org/10.1016/j.rmcr.2022.101669 |
FullText URL | fulltext.pdf |
---|---|
Author | Kitamura, Wataru| Asada, Noboru| Tabata, Tetsuya| Shibata, Rei| Nishi, Tatsuya| Kato, Yuka| Takasuka, Hiroki| Fujiwara, Hideaki| Ennishi, Daisuke| Nishimori, Hisakazu| Fujii, Nobuharu| Matsuoka, Ken-Ichi| Kiura, Katsuyuki| Yoshino, Tadashi| Maeda, Yoshinobu| |
Keywords | marginal zone lymphoma diffuse large B-cell lymphoma anterior mediastinum cystic lesions |
Published Date | 2022 |
Publication Title | Journal Of Clinical And Experimental Hematopatholo |
Volume | volume62 |
Issue | issue1 |
Publisher | The Japanese Society for Lymphoreticular Tissue Research |
Start Page | 35 |
End Page | 40 |
ISSN | 1346-4280 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © 2021 The Japanese Society for Lymphoreticular Tissue Research |
File Version | publisher |
PubMed ID | 34840205 |
DOI | 10.3960/jslrt.21010 |
Web of Science KeyUT | 000766876600003 |
Related Url | isVersionOf https://doi.org/10.3960/jslrt.21010 |
FullText URL | fulltext.pdf |
---|---|
Author | Makimoto, Go| Misawa, Mahito| Maeda, Yoshinobu| Kiura, Katsuyuki| |
Keywords | Chronic myeloid leukemia Chylothorax Dasatinib |
Published Date | 2022 |
Publication Title | Respiratory Medicine Case Reports |
Volume | volume37 |
Publisher | Elsevier |
Start Page | 101662 |
ISSN | 2213-0071 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © 2022 The Authors. |
File Version | publisher |
PubMed ID | 35585905 |
DOI | 10.1016/j.rmcr.2022.101662 |
Web of Science KeyUT | 000807403400006 |
Related Url | isVersionOf https://doi.org/10.1016/j.rmcr.2022.101662 |
FullText URL | fulltext20210810-3.pdf |
---|---|
Author | Nishii, Kazuya| Ohashi, Kadoaki| Watanabe, Hiromi| Makimoto, Go| Nakasuka, Takamasa| Higo, Hisao| Ninomiya, Kiichiro| Kato, Yuka| Kubo, Toshio| Rai, Kammei| Ichihara, Eiki| Hotta, Katsuyuki| Tabata, Masahiro| Maeda, Yoshinobu| Kiura, Katsuyuki| |
Keywords | epidermal growth factor receptor osimertinib bevacizumab cetuximab hypoxia‑inducible factor‑1α transforming growth factor‑α |
Published Date | 2021-7-7 |
Publication Title | Oncology Letters |
Volume | volume22 |
Issue | issue3 |
Publisher | Spandidos Publications |
Start Page | 639 |
ISSN | 1792-1074 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © Nishii et al. This is an open access article distributed under the terms of Creative Commons Attribution License. |
File Version | publisher |
DOI | 10.3892/ol.2021.12900 |
Web of Science KeyUT | 000678494600001 |
Related Url | isVersionOf https://doi.org/10.3892/ol.2021.12900 |
FullText URL | fulltext.pdf |
---|---|
Author | Oda, Naohiro| Tabata, Masahiro| Uno, Masatoshi| Umeda, Yuzo| Kato, Hironari| Kubo, Toshio| Senoo, Satoru| Yagi, Takahito| Fujiwara, Toshiyoshi| Maeda, Yoshinobu| Kiura, Katsuyuki| |
Keywords | pancreas mucinous cystadenocarcinoma carboplatin paclitaxel |
Published Date | 2021-09-15 |
Publication Title | Internal Medicine |
Volume | volume60 |
Issue | issue18 |
Publisher | The Japanese Society of Internal Medicine |
Start Page | 2967 |
End Page | 2971 |
ISSN | 0918-2918 |
NCID | AA10827774 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © 2021 The Japanese Society of Internal Medicine |
File Version | publisher |
PubMed ID | 33814494 |
DOI | 10.2169/internalmedicine.6730-20 |
Web of Science KeyUT | 000697279400013 |
Related Url | isVersionOf https://doi.org/10.2169/internalmedicine.6730-20 |
FullText URL | fulltext.pdf |
---|---|
Author | Okawa, Sachi| Rai, Kammei| Fujii, Nobuharu| Gion, Yuka| Ninomiya, Kiichiro| Kato, Yuka| Taniguchi, Akihiko| Kubo, Toshio| Ichihara, Eiki| Ohashi, Kadoaki| Miyahara, Nobuaki| Hotta, Katsuyuki| Tabata, Masahiro| Maeda, Yoshinobu| Kiura, Katsuyuki| |
Keywords | EGFR IgG4-related disease marginal zone lymphoma osimertinib |
Published Date | 2021-09-01 |
Publication Title | Internal Medicine |
Volume | volume60 |
Issue | issue17 |
Publisher | The Japanese Society of Internal Medicine |
Start Page | 2831 |
End Page | 2837 |
ISSN | 0918-2918 |
NCID | AA10827774 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © 2021 The Japanese Society of Internal Medicine |
File Version | publisher |
PubMed ID | 33775999 |
DOI | 10.2169/internalmedicine.6470-20 |
Web of Science KeyUT | 000695856000020 |
Related Url | isVersionOf https://doi.org/10.2169/internalmedicine.6470-20 |
FullText URL | fulltext.pdf |
---|---|
Author | Katsui, Kuniaki| Ogata, Takeshi| Sugiyama, Soichi| Yoshio, Kotaro| Kuroda, Masahiro| Hiraki, Takao| Kiura, Katsuyuki| Maeda, Yoshinobu| Toyooka, Shinichi| Kanazawa, Susumu| |
Published Date | 2021-06-04 |
Publication Title | scientific reports |
Volume | volume11 |
Issue | issue1 |
Publisher | Nature Research |
Start Page | 11882 |
ISSN | 2045-2322 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © The Author(s) 2021 |
File Version | publisher |
PubMed ID | 34088965 |
DOI | 10.1038/s41598-021-91449-z |
Web of Science KeyUT | 000678611200010 |
Related Url | isVersionOf https://doi.org/10.1038/s41598-021-91449-z |
Title Alternative | The 61st Annual Meeting of the Japan Lung Cancer Society: Eradication of lung cancer 2020 |
---|---|
FullText URL | 133_80.pdf |
Author | Kiura, Katsuyuki| |
Publication Title | Journal of Okayama Medical Association |
Published Date | 2021-04-01 |
Volume | volume133 |
Issue | issue1 |
Start Page | 80 |
End Page | 82 |
ISSN | 0030-1558 |
Related Url | isVersionOf https://doi.org/10.4044/joma.133.80 |
language | Japanese |
Copyright Holders | Copyright (c) 2021 岡山医学会 |
File Version | publisher |
DOI | 10.4044/joma.133.80 |
NAID | 130008034816 |
FullText URL | fulltext.pdf |
---|---|
Author | Watanabe, Kenta| Katsui, Kuniaki| Sugiyama, Soichiro| Yoshio, Kotaro| Kuroda, Masahiro| Hiraki, Takao| Kiura, Katsuyuki| Maeda, Yoshinobu| Toyooka, Shinichi| Kanazawa, Susumu| |
Keywords | Clinical pathology Elderly Non-small cell lung carcinoma Radiosurgery Stereotactic body radiation therapy |
Published Date | 2021-02-23 |
Publication Title | Radiation Oncology |
Volume | volume16 |
Issue | issue1 |
Publisher | BMC |
Start Page | 39 |
ISSN | 1748-717X |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © The Author(s) 2021. |
File Version | publisher |
PubMed ID | 33622369 |
DOI | 10.1186/s13014-021-01769-7 |
Web of Science KeyUT | 000623175000001 |
Related Url | isVersionOf https://doi.org/10.1186/s13014-021-01769-7 |
JaLCDOI | 10.18926/AMO/61429 |
---|---|
FullText URL | 75_1_15.pdf |
Author | Katsui, Kuniaki| Ogata, Takeshi| Tada, Akihiro| Sugiyama, Soichi| Yoshio, Kotaro| Kuroda, Masahiro| Kiura, Katsuyuki| Maeda, Yoshinobu| Toyooka, Shinichi| Hiraki, Takao| Kanazawa, Susumu| |
Abstract | The aim of this study was to investigate whether volumetric positron emission tomography (PET) parameters are prognostic predictors in stage III non-small cell lung cancer patients receiving definitive concurrent chemo-radiotherapy (CCRT) with cisplatin/docetaxel. Cases involving definitive CCRT were reviewed retrospectively, and the maximum standardized uptake value, metabolic tumor volume (MTV) and total lesion glycolysis (TLG) were calculated. The relationships between these PET parameters and prognosis were analyzed. MTV and TLG were significant predictors of distant metastasis-free survival (DMFS) (p = 0.0003 and 0.0005, respectively) and progression-free survival (PFS) (p = 0.001 and 0.0007, respectively). The three-year DMFS rates in patients with low and high MTV were 13.3% and 64.6%, respectively, and the corresponding values in those with low and high TLG were 13.3% and 65.2%, respectively. The three-year PFS rates in patients with low and high MTV were 13.3% and 57.8%, respectively, and the corresponding values in patients with low and high TLG were 13.3% and 57.8%, respectively. However, MTV and TLG were not predictors of local control or overall sur-vival. We demonstrated that volumetric PET parameters were predictors of patients receiving definitive CCRT. Our findings contradict the findings of previous reports and warrant further research to validate them. |
Keywords | volumetric positron emission tomography parameters distant metastasis-free survival chemoradiotherapy cisplatin/docetaxel non-small cell lung cancer |
Amo Type | Original Article |
Publication Title | Acta Medica Okayama |
Published Date | 2021-02 |
Volume | volume75 |
Issue | issue1 |
Publisher | Okayama University Medical School |
Start Page | 15 |
End Page | 23 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
Copyright Holders | CopyrightⒸ 2021 by Okayama University Medical School |
File Version | publisher |
Refereed | True |
PubMed ID | 33649609 |
FullText URL | fulltext.pdf |
---|---|
Author | Harada, Daijiro| Isozaki, Hideko| Kozuki, Toshiyuki| Yokoyama, Toshihide| Yoshioka, Hiroshige| Bessho, Akihiro| Hosokawa, Shinobu| Takata, Ichiro| Takigawa, Nagio| Hotta, Katsuyuki| Kiura, Katsuyuki| Okayama Lung Cancer Study Group| |
Keywords | Alectinib anaplastic lymphoma kinase crizotinib drug therapy non-small cell lung carcinoma |
Published Date | 2021-01-20 |
Publication Title | Thoracic Cancer |
Volume | volume12 |
Issue | issue5 |
Publisher | Wiley |
Start Page | 643 |
End Page | 649 |
ISSN | 1759-7706 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © 2021 The Authors. |
File Version | publisher |
PubMed ID | 33470536 |
DOI | 10.1111/1759-7714.13825 |
Web of Science KeyUT | 000608856400001 |
Related Url | isVersionOf https://doi.org/10.1111/1759-7714.13825 |
FullText URL | fulltext.pdf |
---|---|
Author | Nishii, Kazuya| Inoue, Masaaki| Obata, Hideto| Ueda, Yutaka| Kozuki, Toshiyuki| Yamasaki, Masahiro| Moritaka, Tomonori| Awaya, Yoshikazu| Sugimoto, Keisuke| Gemba, Kenichi| Kuyama, Shoichi| Ichikawa, Hirohisa| Shibayama, Takuo| Kubota, Tetsuya| Kodani, Masahiro| Kishino, Daizo| Fujimoto, Nobukazu| Ishikawa, Nobuhisa| Tsubata, Yukari| Ishii, Tomoya| Fujitaka, Kazunori| Hotta, Katsuyuki| Kiura, Katsuyuki| |
Keywords | Database observational study real world data surveillance treatment |
Published Date | 2021-01-12 |
Publication Title | Thoracic Cancer |
Volume | volume12 |
Issue | issue5 |
Publisher | Wiley |
Start Page | 725 |
End Page | 731 |
ISSN | 1759-7706 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © 2020 The Authors. |
File Version | publisher |
PubMed ID | 33434415 |
DOI | 10.1111/1759-7714.13789 |
Web of Science KeyUT | 000606961500001 |
Related Url | isVersionOf https://doi.org/10.1111/1759-7714.13789 |
FullText URL | fulltext.pdf |
---|---|
Author | Watanabe, Hiromi| Ichihara, Eiki| Kayatani, Hiroe| Makimoto, Go| Ninomiya, Kiichiro| Nishii, Kazuya| Higo, Hisao| Ando, Chihiro| Okawa, Sachi| Nakasuka, Takamasa| Kano, Hirohisa| Hara, Naofumi| Hirabae, Atsuko| Kato, Yuka| Ninomiya, Takashi| Kubo, Toshio| Rai, Kammei| Ohashi, Kadoaki| Hotta, Katsuyuki| Tabata, Masahiro| Maeda, Yoshinobu| Kiura, Katsuyuki| |
Published Date | 2021-01-07 |
Publication Title | Cancer science |
Publisher | Wiley |
ISSN | 1347-9032 |
NCID | AA11808050 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © 2021 The Authors. |
File Version | publisher |
PubMed ID | 33410241 |
DOI | 10.1111/cas.14801 |
NAID | 120007008532 |
Web of Science KeyUT | 000630136900001 |
Related Url | isVersionOf https://doi.org/10.1111/cas.14801 |
FullText URL | fulltext.pdf |
---|---|
Author | Nishii, Kazuya| Ohashi, Kadoaki| Tamura, Tomoki| Ninomiya, Kiichiro| Matsubara, Takehiro| Senoo, Satoru| Kano, Hirohisa| Watanabe, Hiromi| Oda, Naohiro| Makimoto, Go| Higo, Hisao| Kato, Yuka| Ninomiya, Takashi| Kubo, Toshio| Yamamoto, Hiromasa | Tomida, Shuta| Hotta, Katsuyuki| Tabata, Masahiro| Toyooka, Shinichi| Maeda, Yoshinobu| Kiura, Katsuyuki| |
Keywords | non-small cell lung cancer epidermal growth factor receptor mutations droplet digital PCR exhaled breath condensate EGFR-TKIs |
Published Date | 2020-12 |
Publication Title | Oncology Letters |
Volume | volume20 |
Issue | issue6 |
Publisher | Spandidos Publications |
Start Page | 393 |
ISSN | 1792-1074 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
File Version | publisher |
PubMed ID | 33193853 |
DOI | 10.3892/ol.2020.12256 |
Web of Science KeyUT | 000595649300005 |
Related Url | isVersionOf https://doi.org/10.3892/ol.2020.12256 |
JaLCDOI | 10.18926/AMO/60802 |
---|---|
FullText URL | 74_5_423.pdf |
Author | Hirabae, Atsuko| Ichihara, Eiki| Sunami, Ryota| Ota, Moeko| Iwamoto, Yoshitaka| Maeda, Yoshinobu| Kiura, Katsuyuki| |
Abstract | We report a case of late-onset hyperprogressive disease after cessation of a PD-1 inhibitor. A male was diagnosed with metastatic lung adenocarcinoma with little progression for 2 months before treatment. He received pembrolizumab as a second-line treatment and was subsequently prescribed docetaxel for 3 months until a slight increase in pleural effusion. At the time of progression to docetaxel, he commenced prednisolone because of immune-system-related diarrhea. After that, his general condition rapidly worsened with severe fatigue and hypoxia. Computed tomography revealed a massive increase of pleural effusion and replacement of almost the entire liver with cancer over a period of 5 weeks. |
Keywords | lung cancer immune checkpoint inhibitors pembrolizumab hyperprogression |
Amo Type | Case Report |
Publication Title | Acta Medica Okayama |
Published Date | 2020-10 |
Volume | volume74 |
Issue | issue5 |
Publisher | Okayama University Medical School |
Start Page | 423 |
End Page | 425 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
Copyright Holders | CopyrightⒸ 2020 by Okayama University Medical School |
File Version | publisher |
Refereed | True |
PubMed ID | 33106698 |
Web of Science KeyUT | 000581970100007 |
NAID | 120006892928 |
JaLCDOI | 10.18926/AMO/60796 |
---|---|
FullText URL | 74_5_371.pdf |
Author | Makimoto, Go| Ohashi, Kadoaki| Maeda, Yoshinobu| Kiura, Katsuyuki| |
Abstract | The prognosis of advanced non-small cell lung cancer (NSCLC) patients has improved in recent decades, especially for patients with an oncogenic driver mutation. Anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (TKIs) are effective for patients with the echinoderm microtubule-associated protein-like 4-ALK fusion gene. Several ALK-TKIs have been established: the first-generation ALK-TKI, crizotinib; second-generation ALK-TKIs, alectinib and ceritinib; and third-generation ALK-TKI, lorlatinib. Some ALK-TKIs are effective for tumors that are resistant to other ALK-TKIs; however, as is known in epidermal growth factor receptormutant lung cancer, tumor resistance is inevitable. ALK-positive NSCLCs acquire resistance via various mechanisms, making it a heterogeneous disease. Therefore, it is necessary to develop next-generation treatment strategies, such as the use of next-generation ALK-TKIs for secondary mutations, or combination therapies with ALK-TKIs and other TKIs. In this review, we summarize the development and use of ALK-TKIs, prior pivotal clinical trials, and resistance mechanisms. |
Keywords | lung cancer anaplastic lymphoma kinase tyrosine kinase inhibitors resistance mechanism |
Amo Type | Review |
Publication Title | Acta Medica Okayama |
Published Date | 2020-10 |
Volume | volume74 |
Issue | issue5 |
Publisher | Okayama University Medical School |
Start Page | 371 |
End Page | 379 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
Copyright Holders | CopyrightⒸ 2020 by Okayama University Medical School |
File Version | publisher |
Refereed | True |
PubMed ID | 33106692 |
Web of Science KeyUT | 000581970100001 |
NAID | 120006892922 |
FullText URL | fulltext.pdf |
---|---|
Author | Senoo, Satoru| Miyahara, Nobuaki| Taniguchi, Akihiko| Oda, Naohiro| Itano, Junko| Higo, Hisao| Hara, Naofumi| Watanabe, Hiromi| Kano, Hirohisa| Suwaki, Toshimitsu| Fuchimoto, Yasuko| Kajimoto, Kazuhiro| Ichikawa, Hirohisa| Kudo, Kenichiro| Shibayama, Takuo| Tanimoto, Yasushi| Kuyama, Shoichi| Kanehiro, Arihiko| Maeda, Yoshinobu| Kiura, Katsuyuki| Okayama Respiratory Disease Study Group (ORDSG)| |
Published Date | 2020-08-27 |
Publication Title | PLoS ONE |
Volume | volume15 |
Issue | issue8 |
Publisher | Public Library of Science |
Start Page | e0236935 |
ISSN | 1932-6203 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © 2020 Senoo et al. |
File Version | publisher |
PubMed ID | 32853277 |
DOI | 10.1371/journal.pone.0236935 |
Web of Science KeyUT | 000566948800009 |
Related Url | isVersionOf https://doi.org/10.1371/journal.pone.0236935 |
FullText URL | fulltext.pdf |
---|---|
Author | Sugiura, Hiroyuki| Nishimori, Hisakazu| Nishii, Kazuya| Toji, Tomohiro| Fujii, Keiko| Fujii, Nobuharu| Matsuoka, Ken-ichi| Nakata, Koh| Kiura, Katsuyuki| Maeda, Yoshinobu| |
Keywords | pulmonary alveolar proteinosis primary myelofibrosis autopsy ruxolitinib |
Published Date | 2020-08-15 |
Publication Title | Internal Medicine |
Volume | volume59 |
Issue | issue16 |
Start Page | 2023 |
End Page | 2028 |
ISSN | 0918-2918 |
NCID | AA10827774 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © 2020 by The Japanese Society of Internal Medicine |
File Version | publisher |
PubMed ID | 32448830 |
DOI | 10.2169/internalmedicine.4082-19 |
Web of Science KeyUT | 000563078400014 |
Related Url | isVersionOf https://doi.org/10.2169/internalmedicine.4082-19 |